The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Luigi Gennari

University of Siena

Department of Internal Medicine

Endocrine-Metabolic Sciences and Biochemistry

Policlinico Le Scotte

[email]@unisi.it

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • University of Siena, Department of Internal Medicine, Endocrine-Metabolic Sciences and Biochemistry, Policlinico Le Scotte. 2003 - 2012
  • Institute of Internal Medicine, University of Siena, Italy. 2001 - 2002
  • Department of Internal Medicine, University of Florence, Viale Pieraccini 6, 50135 Florence, Italy. 2002
  • Institute of Internal Medicine, Policlinico Le Scotte, Viale Bracci, 53100, Italy. 2000

References

  1. Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes. Gennari, L., Merlotti, D., Valenti, R., Ceccarelli, E., Ruvio, M., Pietrini, M.G., Capodarca, C., Franci, M.B., Campagna, M.S., Calabrò, A., Cataldo, D., Stolakis, K., Dotta, F., Nuti, R. J. Clin. Endocrinol. Metab. (2012) [Pubmed]
  2. Pharmacokinetic evaluation of toremifene and its clinical implications for the treatment of osteoporosis. Gennari, L., Merlotti, D., Stolakis, K., Nuti, R. Expert. Opin. Drug. Metab. Toxicol (2012) [Pubmed]
  3. Lasofoxifene, from the preclinical drug discovery to the treatment of postmenopausal osteoporosis. Gennari, L., Merlotti, D., Stolakis, K., Nuti, R. Expert. Opin. Drug. Discov (2011) [Pubmed]
  4. Aromatase activity and bone loss. Gennari, L., Merlotti, D., Nuti, R. Adv. Clin. Chem (2011) [Pubmed]
  5. SQSTM1 gene analysis and gene-environment interaction in Paget's disease of bone. Gennari, L., Gianfrancesco, F., Di Stefano, M., Rendina, D., Merlotti, D., Esposito, T., Gallone, S., Fusco, P., Rainero, I., Fenoglio, P., Mancini, M., Martini, G., Bergui, S., De Filippo, G., Isaia, G., Strazzullo, P., Nuti, R., Mossetti, G. J. Bone Miner. Res. (2010) [Pubmed]
  6. Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifene. Gennari, L., Merlotti, D., Nuti, R. Clin. Interv. Aging (2010) [Pubmed]
  7. The use of intravenous aminobisphosphonates for the treatment of Paget's disease of bone. Gennari, L., Merlotti, D., Mossetti, G., Rendina, D., De Paola, V., Martini, G., Nuti, R. Mini. Rev. Med. Chem (2009) [Pubmed]
  8. Ospemifene use in postmenopausal women. Gennari, L., Merlotti, D., Valleggi, F., Nuti, R. Expert. Opin. Investig. Drugs (2009) [Pubmed]
  9. Update on the pharmacogenetics of the vitamin D receptor and osteoporosis. Gennari, L., Merlotti, D., De Paola, V., Martini, G., Nuti, R. Pharmacogenomics (2009) [Pubmed]
  10. Lasofoxifene, a new selective estrogen receptor modulator for the treatment of osteoporosis and vaginal atrophy. Gennari, L. Expert. Opin. Pharmacother (2009) [Pubmed]
  11. Glucocorticoid-induced osteoporosis: hope on the HORIZON. Gennari, L., Bilezikian, J.P. Lancet (2009) [Pubmed]
  12. Perspectives in the treatment and prevention of osteoporosis. Gennari, L., Merlotti, D., Nuti, R. Drugs. Today (2009) [Pubmed]
  13. Raloxifene in breast cancer prevention. Gennari, L., Merlotti, D., Paola, V.D., Nuti, R. Expert. Opin. Drug. Saf (2008) [Pubmed]
  14. Does calcium supplementation reduce the risk of osteoporotic fracture and bone loss?. Gennari, L., Martini, G. Nature Clinical Practice. Rheumatology (2008) [Pubmed]
  15. Estrogen and fracture risk in men. Gennari, L., Khosla, S., Bilezikian, J.P. J. Bone Miner. Res. (2008) [Pubmed]
  16. Selective estrogen receptor modulators for postmenopausal osteoporosis: current state of development. Gennari, L., Merlotti, D., Valleggi, F., Martini, G., Nuti, R. Drugs. Aging (2007) [Pubmed]
  17. Steroid hormone receptor gene polymorphisms and osteoporosis: a pharmacogenomic review. Gennari, L., De Paola, V., Merlotti, D., Martini, G., Nuti, R. Expert. Opin. Pharmacother (2007) [Pubmed]
  18. Lasofoxifene: a new type of selective estrogen receptor modulator for the treatment of osteoporosis. Gennari, L. Drugs. Today (2006) [Pubmed]
  19. Lasofoxifene: a third-generation selective estrogen receptor modulator for the prevention and treatment of osteoporosis. Gennari, L., Merlotti, D., Martini, G., Nuti, R. Expert. Opin. Investig. Drugs (2006) [Pubmed]
  20. Paget's disease of bone in Italy. Gennari, L., Merlotti, D., Martini, G., Nuti, R. J. Bone Miner. Res. (2006) [Pubmed]
  21. Estrogen receptor gene polymorphisms and the genetics of osteoporosis: a HuGE review. Gennari, L., Merlotti, D., De Paola, V., Calabrò, A., Becherini, L., Martini, G., Nuti, R. Am. J. Epidemiol. (2005) [Pubmed]
  22. Oral ibandronic acid. Gennari, L. IDrugs (2005) [Pubmed]
  23. Prevalence of Paget's disease of bone in Italy. Gennari, L., Di Stefano, M., Merlotti, D., Giordano, N., Martini, G., Tamone, C., Zatteri, R., De Lucchi, R., Baldi, C., Vattimo, A., Capoccia, S., Burroni, L., Geraci, S., De Paola, V., Calabrò, A., Avanzati, A., Isaia, G., Nuti, R. J. Bone Miner. Res. (2005) [Pubmed]
  24. Lasofoxifene (Pfizer). Gennari, L. Curr. Opin. Investig. Drugs (2005) [Pubmed]
  25. Ospemifene Hormos. Gennari, L. Curr. Opin. Investig. Drugs (2004) [Pubmed]
  26. Aromatase activity and bone homeostasis in men. Gennari, L., Nuti, R., Bilezikian, J.P. J. Clin. Endocrinol. Metab. (2004) [Pubmed]
  27. Longitudinal association between sex hormone levels, bone loss, and bone turnover in elderly men. Gennari, L., Merlotti, D., Martini, G., Gonnelli, S., Franci, B., Campagna, S., Lucani, B., Dal Canto, N., Valenti, R., Gennari, C., Nuti, R. J. Clin. Endocrinol. Metab. (2003) [Pubmed]
  28. PTH in the pathogenesis and treatment of glucocorticoid-induced osteoporosis. Gennari, C., Gonnelli, S., Bruni, D., Gennari, L., Brandi, M.L. Front. Horm. Res (2002) [Pubmed]
  29. Genetics of osteoporosis: role of steroid hormone receptor gene polymorphisms. Gennari, L., Becherini, L., Falchetti, A., Masi, L., Massart, F., Brandi, M.L. J. Steroid Biochem. Mol. Biol. (2002) [Pubmed]
  30. Calcium and vitamin D nutrition and bone disease of the elderly. Gennari, C. Public. Health. Nutr (2001) [Pubmed]
  31. World Congress on Osteoporosis 2000. 15-18 June 2000, Chicago, IL, USA. Gennari, C. IDrugs (2000) [Pubmed]
 
WikiGenes - Universities